Dec. 9 at 1:27 AM
$ADVM Equity Corporate Actions Alert #2025 - 666
Information Regarding the Tender Offer of Adverum Biotechnologies, Inc. (ADVM)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-666
The tender offer by Eli Lilly and Company. (
$LLY) to acquire all of the outstanding common stock of Adverum Biotechnologies, Inc. (ADVM) is scheduled to expire one minute after 11:59 p.m. ET, on December 8, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on December 9, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on December 8, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (December 9th) and will be suspended effective December 10, 2025.
ADVM shareholders will receive
$3.56 and a CVR for each share held at closing.
